Human A Disintegrin And Metalloprotease 19 (ADAM19) ELISA Kit

ADAM19, also known as meltrin-beta, is a type I transmembrane metalloproteinase implicated in extracellular matrix remodeling, ectodomain shedding of membrane-bound signaling molecules, and cell-cell adhesion across developmental and pathological contexts. Researchers investigating cancer invasion, cardiac morphogenesis, or inflammatory signaling can apply this quantitative immunoassay from Assay Genie to measure native human ADAM19 levels in tissue homogenates and cell lysates.

The kit is supplied with pre-coated assay plates, lyophilized standards, detection antibodies, buffers, and substrate, and provides 96 individual determinations per box. Colorimetric absorbance readouts allow quantitation on standard microplate equipment, and the validated protocol accommodates tissue homogenates and cell lysates without specialized instrumentation beyond a plate reader and washer.

Intended for research use only, the assay enables hypothesis-driven measurement of ADAM19 abundance in cell and tissue systems where this metalloprotease has been implicated in disease mechanisms. Standard ELISA best practices apply, including the use of appropriate dilution series for unknown samples and validation of parallelism with the supplied standard curve.